跳至主要内容
临床试验/TCTR20200806007
TCTR20200806007已完成未知

Results of Infliximab Theraphy in Behcet Uveitis

one0 个研究点目标入组 35 人开始时间: 2020年8月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
one
入组人数
35

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
19 Years 至 60 Years(—)
性别
All

入选标准

  • Patients that were diagnosed with Behcet's disease on the basis of the criteria proposed by the International Study Group for Behcet's disease and had related uveitis were included to the study group.
  • Cases that were switched from conventional IMT to IFX therapy and had a minimum of 18 months of follow-up under IFX treatment were included to the study group

排除标准

  • Cases attending irregular follow-ups and those with other retinal diseases were excluded from the study. Patients with a history of tuberculosis, active HBV-HCV-HIV and fungal infections were not included to the study. Patients with malignancy, liver, renal, cardiac or pulmonary insufficiency and diagnosis or suspicion of multiple sclerosis were excluded from the study.

研究者

发起方
one

相似试验